-The Hindustan Times The recent release of The Lancet's special edition on Maternal and Child Nutrition in Delhi provided an occasion to debate the relevance of its recommendations for India. The discourse was enlivened by a statement, released ahead of the event by several Indian health experts, challenging the content and intent of some of the suggested interventions. Three authors of The Lancet series and many of the critics who issued that statement...
More »SEARCH RESULT
Total Matching Records found : 2364
'19% affluent teens in UP are obese' -Shailvee Sharda
-The Times of India LUCKNOW: In a state infamous for malnutrition, one out of five teens going to private schools is either overweight or obese. This has been revealed in a study conducted by National Diabetes, Obesity and Cholesterol Foundation (N-DOC). The study covered more than 49,000 school children in eight cities, including 23,006 children in Lucknow, Agra and Allahabad. The other cities were New Delhi, Jaipur, Mumbai, Dehradun and Pantnagar. The...
More »United States finds pesticide residue in basmati, exports plunge -Madhvi Sally
-The Economic Times NEW DELHI: Basmati rice exports to the US have plunged because many Indian firms are under an import alert by the US authorities, leading to a detailed scrutiny for pesticide residue in every grain being shipped out. This has raised costs, upset schedules and obstructed sales, prompting exporters to seek government intervention. In the first quarter of calendar year 2013, exports were down to 19,583 tonne. With 31 Indian...
More »Lancet rejects 'commercial exploitation' of nutrition campaign -Trithesh Nandan
-Governance Now Magazine turns down red flag raised by a group of experts; says private food manufacturers part of campaign but "harmful" soft drink makers are not Days after a group of independent experts criticised the "commercial exploitation" of malnutrition and said the private sector should be kept out of any crusade against malnutrition, the Lancet, the renowned British medical journal, has advocated just the opposite, saying private players ought to...
More »Ranbaxy drugs fine, say WHO and UK regulator -Rema Nagarajan
-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...
More »
